Under construction – not a live service
Sign in
Taking people in FranceNo phase

Brain MRI Scans to Predict Recovery After Clot Removal for Stroke

Uses brain MRI scans to study adults with a blocked middle brain artery stroke.

Plain-language title generated from the registry record
Registry title: Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)

Key facts

Where
Poitiers, FranceSee the site

Where in France

  • CHU PoitiersPoitiers, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Poitiers University Hospital
Trial code
NCT04651010
Record updated
13 October 2026
Original description
Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months.Read full original descriptionShow less

Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT

Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months.

We aim to find early radiologic predictive factors for favorable clinical outcome in this population of patients.

Inclusion: Patients aged ≥ 18 years old; Hospitalized at the Poitiers University Hospital; Acute middle cerebral artery occlusion diagnosed by CT-scan or MRI; NIHSS score ≥ 6 at admission; To be treated by thrombectomy with or without fibrinolysis; Written information delivered to the patient or his relatives concerning the study and its benefit and risk.

Exclusion: Patients or relatives whom a loyal information about the study cannot be given; Patient with cognitive impairments before MRI; Patients who cannot undergo MRI because of contraindications; Patients too deteriorated to tolerate one hour long exam.

ClinicalTrials.gov NCT04651010